Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
Pharma Publishing & Media Europe from Mol, company number BE0479719834, closed financial year 2025 with a result of € -8,838 after tax. For that financial year Pharma Publishing & Media Europe recorded a gross margin of € -1,834 and equity of € 183,227. Compared with financial year 2024, the result moved from € -8,569 to € -8,838. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 23, 2026.
€ 183,227
▼ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -8,838
▼ 3 % more loss than in 2024
Profit after tax over the fiscal year.
€ 12,155
▼ 76% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 174,700.
People and assets in 2025
€ 5,069
▼ 42% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 184,865
▲ 12% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 3,127
▲ € 2,886 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -13,371 | € -33,982 | € -3,855 | € -1,834 | ▲ € 2,021 |
| Profit after taxes | € -56,242 | € -36,652 | € -8,569 | € -8,838 | ▼ € 270 |
| Equity | € 237,285 | € 200,633 | € 192,065 | € 183,227 | ▼ 5% |
| Total debts | € 7,983 | € 6,346 | € 167,066 | € 187,992 | ▲ 13% |
| Cash | € 1,681 | € 1,449 | € 51,017 | € 12,155 | ▼ 76% |
| Land & buildings | € 746 | - | - | - | |
| Retained profit | € 230,618 | € 192,106 | € 183,538 | € 174,700 | ▼ 5% |
| Balance sheet total | € 245,268 | € 206,980 | € 359,131 | € 371,219 | ▲ 3% |
| Employees (FTE) | 0.9 | - | - | - |
Key figures of Pharma Publishing & Media Europe, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Pharma Publishing & Media Europe?
What happened at Pharma Publishing & Media Europe in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 8,838. filed late Source: NBB ↗
- Guido Lenaerts became a director. NBB
- Lai Ha Lasia Tang became a director. NBB
- New establishment in Mol. KBO
- Start of the company according to the CBE. KBO
In short
From € 56,242 loss in 2022 to € 8,838 loss in 2025.
Paid € 503 in corporate taxes since 2022.
A new publication or filing at Pharma Publishing & Media Europe? We notify you, reason included.
Follow Pharma Publishing & Media EuropeDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Pharma Publishing & Media Europe are Lai Ha Lasia Tang and Guido Lenaerts.
Directors
According to the 2025 annual accounts
Lai Ha Lasia Tang
Director
since 2020
Guido Lenaerts
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Grenoblelaan 5
2400 Mol
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0479.719.834
- VAT number
- BE 0479.719.834
- Registered office
- Grenoblelaan 5, 2400 Mol
- Names & denominations
- Pharma Publishing & Media Europe
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 March 2003
- Peppol
- Active · Active since 10 Sept 2025
- Activities · NACE
Overige zakelijke dienstverlening, neg
Overige zakelijke dienstverlening, n.e.g.